Handelsbanken Fonder
IMNM icon

Handelsbanken Fonder’s Immunome IMNM Stock Holding History

Handelsbanken Fonder’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-180,000
Closed -$2.11M – 1522
2025
Q3 		$2.11M Sell
180,000
-20,000
-10% -$199K 0.01% 706
2025
Q2 		$1.86M Hold
200,000
– – 0.01% 687
2025
Q1 		$1.35M Hold
200,000
– – 0.01% 817
2024
Q4 		$2.12M Sell
200,000
-30,000
-13% -$363K 0.01% 655
2024
Q3 		$3.36M Hold
230,000
– – 0.01% 509
2024
Q2 		$2.78M Buy
230,000
+45,000
+24% +$704K 0.01% 503
2024
Q1 		$4.57M Buy
+185,000
New +$3.75M 0.02% 462

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Handelsbanken Fonder's IMNM Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Immunome (IMNM) in Q4 2025, closing a stake of 180,000 shares — an estimated $2.11M sold.

Handelsbanken Fonder first reported a position in IMNM in Q1 2024 and held it in 7 quarters. The position peaked at $4.57M in Q1 2024. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Handelsbanken Fonder reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 180,000 Immunome shares in Q4 2025, an estimated $2.11M.
  • Handelsbanken Fonder first reported a position in Immunome in Q1 2024 and held it in 7 quarters.
  • Handelsbanken Fonder's Immunome position peaked at $4.57M in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.